Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Published:2023-06-01 Issue:25 Volume:44 Page:2292-2304
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Tokgozoglu Lale¹^ORCID,Morrow David A²,Nicholls Stephen J³

Affiliation:

1. Department of Cardiology, Hacettepe University Faculty of Medicine , Ankara , Turkey

2. TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School , Boston, MA , USA

3. Victorian Heart Institute, Monash University , Melbourne , Australia

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/44/25/2292/50777982/ehad275.pdf

Reference52 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel;Ference;Eur Heart J,2017

2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

3. SCORE2 Risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe;SCORE2 working group and ESC Cardiovascular risk collaboration;Eur Heart J,2021

4. A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage study;Mortensen;J Ame Coll Cardiol,2016

5. Statin eligibility for primary prevention of cardiovascular disease according to 2021 European prevention guidelines compared with other international guidelines;Mortensen;JAMA Cardiol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?;Current Atherosclerosis Reports;2024-08-16

2. Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease;Medicina Clínica;2024-05

3. Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease;Medicina Clínica (English Edition);2024-05

4. Targeting hypercholesterolaemia: challenges and opportunities;European Heart Journal;2023-07-01

5. Carotid total plaque area as an independent predictor of short-term subclinical polyvascular atherosclerosis progression and major adverse cardiac and cerebrovascular events;Therapeutic Advances in Cardiovascular Disease;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3